Bullhorn icon Welcome to Long Covid Studies! For background on this project, please read the about page or this recent article in The Sick Times.

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
Summary:
The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Sti...
Type:
Interventional
Status:
Recruiting
Interventions:

percutaneous electrical nerve-field stimulation, PENFS, percutaneous electrical nerve-field stimulation, PENFS (sham device), percutaneous electrical nerve-field stimulation, PENFS (COVID active device)

Locations:

Orange, United States

Last Updated:

October 16, 2026

Details
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Summary:
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of s...
Type:
Interventional
Status:
Recruiting
Interventions:

S-892216-LAI, Placebo

Locations:

Cypress, United States; Lenexa, United States; 

Last Updated:

October 14, 2026

Details
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Summary:
Background: COVID-19 can cause problems in different parts of the body. For most people, it causes ...
Type:
Interventional
Status:
Enrolling by Invitation
Interventions:

IV normal saline, IV immunoglobulin

Locations:

Bethesda, United States

Last Updated:

October 10, 2026

Details
LIFT: Life Improvement Trial
Summary:
The LIFT will be conducted at Brigham and Women's Hospital (BWH) of Harvard Medical School, focusing...
Type:
Interventional
Status:
Recruiting
Interventions:

Pyridostigmine, Low-Dose Naltrexone, Placebo

Locations:

Boston, United States

Last Updated:

October 9, 2026

Details
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Summary:
The Long-Covid (LC)-Revitalize clinical study is testing repurposed drug treatments for Long Covid, ...
Type:
Interventional
Status:
Recruiting
Interventions:

Pirfenidone, Placebo for pirfenidone, Upadacitinib, Placebo for upadacitinib

Locations:

San Diego, United States; Rio de Janeiro, Brazil;  and 7 more

Last Updated:

October 1, 2026

Details
SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Summary:
This placebo-controlled, randomized, blinded, two-arm phase II study will test the safety and potent...
Type:
Interventional
Status:
Recruiting
Interventions:

Placebo, Sipavibart

Locations:

Fort Lauderdale, United States

Last Updated:

September 24, 2026

Details
Long-Term Study of COVID-19 Infection and Long COVID
Summary:
This study will examine how common Long COVID is and how symptoms may persist over time in people wh...
Type:
Observational
Status:
Recruiting
Locations:

Chapel Hill, United States

Last Updated:

September 24, 2026

Details
Heat thErapy And mobiLity in COVID-19 Survivors
Summary:
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic disea...
Type:
Interventional
Status:
Recruiting
Interventions:

Heat therapy, Sham Control, Walking

Locations:

Omaha, United States

Last Updated:

September 23, 2026

Details
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Summary:
The overarching goal of this study is to determine if baricitinib, as compared to placebo, will impr...
Type:
Interventional
Status:
Recruiting
Interventions:

Baricitinib, Placebo

Locations:

Tucson, United States; Los Angeles, United States;  and 14 more

Last Updated:

September 21, 2026

Details
A Study to Examine Anktiva for the Treatment of COVID-19.
Summary:
This study will examine the safety and effectiveness of Anktiva in treating patients with Long COVID...
Type:
Interventional
Status:
Recruiting
Interventions:

Anktiva

Locations:

El Segundo, United States

Last Updated:

September 21, 2026

Details
Showing 1 to 10 of 60 Studies